Skip to main content
. 2023 Jun 25;15(3):764–777. doi: 10.3390/neurolint15030048

Table 2.

Sleep duration and stroke incidence—prospective studies.

Study Sample Size Sleep Duration (Hours/Day) Long Sleeper % Follow-Up Duration (Years) Hazard Ratio (95% CI) Country
Long Short Long Short
2011, Kronholm [41] 24,025 ≥10 ≤5 2.6% 29–34 1.4 1.15 Finland
2020, Zhou [42] 31,750 ≥9 <6 23.9% 6.2 1.23 (1.07–1.41) 1.10 (0.69–1.75) China
2008, Chen [40] 93,175 ≥9 ≤5 4.6% 7.5 1.70 (1.32–2.21) 1.14 (0.97–1.33) USA
1997, Qureshi [43] 7844 >8 <6 8.5% 10 1.5 (1.1–2.0) 1.0 (0.7–1.5) USA
2021, Joundi [16] 82,795 ≥10 <4 1.2% 9.1 2.26 (1.02–5.00) 1.38 (0.63–3.02) Canada
2020, Titova [44] 79,881 ≥9 <7 6.1% 14.6 1.12 (1.03–1.22) 1.04 (0.99–1.09) Sweden
2012, von Ruesten [45] 23,620 ≥9 <6 7.5% 7.8 1.65 (1.00–2.73) 2.06 (1.18–3.59) Europe
2016, Song [46] 95,023 >8 <6 1.7% 7.9 1.29 (1.01–1.64) 0.92 (0.81–1.05) China
2020, Butler [47] 4522 ≥9 <6 4.9% 12 1.32 (1.02–1.70) 1.56 (1.06–2.30) USA
2018, Li [48] 1928 ≥9 <7 10.2% 4.94 2.24 (1.05–4.79) 1.27 (0.75–2.16) China
2015, Leng [49] 9692 >8 <6 10% 9.5 1.46 (1.08–1.98) 1.18 (0.91–1.53) UK
2020, Ji [50] 27,712 >8 <6 18.9% 7 1.40 (1.08–1.75) 1.63 (1.23–2.11) China
2020, Li [51] 2687 >8 <6 30.3% 3.7 1.79 (1.22–2.63) 1.20 (0.72–2.00) China
2018, Petrov [52] 16,733 ≥9 <6 6.8% 6.1 1.71 (1.06–2.76) 1.58 (0.90–2.79) USA
2020, Ye [53] 8968 >9 <6 9.4% 3 2.01 (1.18–3.43) 2.25 (0.97–5.20) China
2015, Helbig [54] 15,746 ≥10 ≤5 4% 14 1.38 (0.98–1.94) 1.36 (0.95–1.94) Germany
2011, Hamazaki [55] 2282 ≥8 <6 22.3% 14 2.25 (0.91–5.57) 1.84 (0.23–4.90) Japan
2013, Westerlund [56] 41,192 ≥8 ≤5 24.2% 13.2 0.87 (0.72–1.04) 1.05 (0.80–1.37) Sweden
2014, Ruiter Petrov [57] 5666 ≥9 <6 5.9% 3 0.96 (0.45–2.05) 1.55 (0.82–2.91) USA
2010, Amagai [58] 11,367 ≥9 <6 15.1% 10.7 1.39 (0.92–2.10) 2.00 (0.93–4.31) Japan
2023, Han [59] 18,876 ≥10 ≤5 3.6% 11.5 2.08 (1.44–3.01) 1.70 (1.23–2.35) UK
2022, Cheng [60] 261,297 >9 <7 2.4% 10.9 1.22 (1.07–1.38) 1.18 (1.11–1.25) UK